- Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: application beyond pulmonary arterial hypertensionRebecca Cogswell
Division of Cardiology, University of California, San Francisco, San Francisco, CA 94117, USA
J Heart Lung Transplant 32:293-8. 2013..The REVEAL score was designed to predict 1-year survival in patients with pulmonary arterial hypertension (PAH) only. It is unknown whether this model is applicable to a more general population of PH patients...
- Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survivalRebecca Cogswell
Division of Cardiology, University of California, San Francisco, San Francisco, CA, USA
J Heart Lung Transplant 31:1165-70. 2012..Multivariate prediction models need to be evaluated in cohorts distinct from the derivation set to determine external validity. In addition, limited data exist on the utility of this model in the prediction of long-term survival...